Pre-Transplant Hemoglobin A1c Predicts Long Term Outcomes Following Heart Transplantation

Hemoglobin A1c, a common metric of glycemic control in diabetics, has been associated with various outcomes in the ambulatory heart failure population. Currently, only end organ damage secondary to diabetes is a contraindication to heart transplant (HT) and no optimal A1c prior to HT has been identified.

Source: The Journal of Heart and Lung Transplantation - March 31, 2018 Category: Transplant Surgery Authors: L.K. Truby, M. Farr, A. Garan, R. Givens, H. Takayama, K. Takeda, M. Yuzefpolskaya, F. Latif, S. Restaino, K. Axsom, Y. Naka, P.C. Colombo, V.K. Topkara Source Type: research